相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The CLL12 trial: ibrutinib vs placebo in treatment-naive, early-stage chronic lymphocytic leukemia
Petra Langerbeins et al.
BLOOD (2022)
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients
Silvia Ramos-Campoy et al.
HAEMATOLOGICA (2022)
Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab
John F. Seymour et al.
BLOOD (2022)
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Larry Mansouri et al.
LEUKEMIA (2022)
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study
Alexander C. Leeksma et al.
HAEMATOLOGICA (2021)
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study
Gian Matteo Rigolin et al.
BLOOD (2021)
Genomic arrays for the identification of high-risk chronic lymphocytic leukemia: ready for prime time?
Antonio Cuneo et al.
HAEMATOLOGICA (2021)
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL
Sameer A. Parikh et al.
BLOOD (2021)
The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib
Adam S. Kittai et al.
BLOOD (2021)
Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study
William G. Wierda et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index
Geffen Kleinstern et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
Adalgisa Condoluci et al.
BLOOD (2020)
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
Panagiotis Baliakas et al.
BLOOD (2019)
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile
I. Del Giudice et al.
LEUKEMIA (2018)
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Michael Hallek et al.
BLOOD (2018)
Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia
Kathy Chun et al.
CANCER GENETICS (2018)
Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group
M. A. Hoechstetter et al.
LEUKEMIA (2017)
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI
Gian Matteo Rigolin et al.
BLOOD (2017)
Guidelines for genomic array analysis in acquired haematological neoplastic disorders
Jacqueline Schoumans et al.
GENES CHROMOSOMES & CANCER (2016)
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations
Gian Matteo Rigolin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data
Michael Hallek
LANCET ONCOLOGY (2016)
Chromosome Aberrations Detected by Conventional Karyotyping Using Novel Mitogens in Chronic Lymphocytic Leukemia: Clinical and Biologic Correlations
Gian Matteo Rigolin et al.
GENES CHROMOSOMES & CANCER (2015)
The Database of Genomic Variants: a curated collection of structural variation in the human genome
Jeffrey R. MacDonald et al.
NUCLEIC ACIDS RESEARCH (2014)
Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?
Anna Puiggros et al.
LEUKEMIA & LYMPHOMA (2013)
Early Versus Deferred Treatment With Combined Fludarabine, Cyclophosphamide and Rituximab (FCR) Improves Event-Free Survival In Patients With High-Risk Binet Stage A Chronic Lymphocytic Leukemia - First Results Of a Randomized German-French Cooperative Phase III Trial
Carmen D. Schweighofer et al.
BLOOD (2013)
Brief report Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with normal FISH: correlations with clinicobiologic parameters
Gian Matteo Rigolin et al.
BLOOD (2012)
High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations
Jennifer Edelmann et al.
BLOOD (2012)
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia
Peter Ouillette et al.
BLOOD (2011)